u/AssociateLate1116 · 353d agono track record yet
INTS - fuck cancer
INTS has a novel tumor treatment breakthrough in FDA trials with major pharma partners, recently raised cash through 2027, and is trading 50% below the capital raise price at only $25M market cap. Author expects 10-20x returns within 18 months.
At post $12.80Now $3.40-73.4% since postedas of Oct 30, 4:45 PM ET
1d-6.6%
3d-14.5%
1w-16.6%
1m-8.2%
3m-26.8%
6m-60.9%
1y—